Compliance is crucial for maintaining product quality, ensuring safety and meeting regulatory standards. Two terms often discussed in this context are GMP and GDP. Though they are key to ensuring the integrity of pharmaceutical products, they focus on different stages of the product lifecy…
A well-executed process validation lifecycle is essential for ensuring product quality, consistency and regulatory compliance. These factors are critical for patient safety and market success. As regulatory frameworks become more complex, companies must approach process validation systematica…
Ensuring pharma IT systems comply with 21 CFR Part 11 is essential. With growing regulatory demands and data security concerns, compliance is crucial for protecting data integrity, maintaining trust and avoiding costly penalties. But what does compliance truly entail and why should it be a to…
IT systems are important in maintaining operations, ensuring compliance and safeguarding data integrity in the pharma industry. However, meeting regulatory requirements for pharmaceutical IT systems can be complex and challenging.
With evolving standards and regulations such as 21 CFR…
In the pharmaceutical industry, regulatory authority inspections are not just a formality—they are a critical safeguard to ensure that products are manufactured, tested, and distributed in a safe, effective, and compliant manner. However, effective inspection readiness goes beyond documentatio…
One common misconception we notice in various parts of the world is that marketing offices are exempt from GDP compliance because they don’t PHYSICALLY handle, store, or distribute medical products. This is a dangerous oversimplification because your marketing office influences WHO distributes…
We use cookies to improve user experience and analyse website traffic. By clicking “Accept“, you agree to our website's cookie use as described in our Cookie Policy.
